Free Trial
NYSE:MCK

McKesson Q1 2026 Earnings Report

McKesson logo
$698.43 +4.89 (+0.71%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$696.85 -1.58 (-0.23%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson EPS Results

Actual EPS
N/A
Consensus EPS
$8.33
Beat/Miss
N/A
One Year Ago EPS
N/A

McKesson Revenue Results

Actual Revenue
N/A
Expected Revenue
$95.93 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

McKesson Announcement Details

Quarter
Q1 2026
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

McKesson Earnings Headlines

Market Crash Warning: How to Protect Your Wealth Before August 12th
China tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alternative Assets reveals 3 urgent moves to protect your portfolio, plus the #1 asset class thriving during crises (hint: it’s not stocks or bonds).
McKesson Raises Quarterly Dividend by 15%
McKesson raises quarterly dividend by 15.5% to $0.82/share
See More McKesson Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like McKesson? Sign up for Earnings360's daily newsletter to receive timely earnings updates on McKesson and other key companies, straight to your email.

About McKesson

McKesson (NYSE:MCK) provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

View McKesson Profile

More Earnings Resources from MarketBeat